Ron Burkle has rejected a $3 billion-plus binding offer for his Americold refrigerated warehouse business from Stephen Schwarzman’s Blackstone Group, The Post had learned. Burkle now plans to cash out of the growing business by taking it public, two sources close to the situation said. A spokesman for Burkle’s Yucaipa declined comment on Blackstone but...
NYS Entity Status
NYS Filing Date
SEPTEMBER 29, 2014
NYS DOS ID#
345 PARK AVENUE 28TH FL
NEW YORK, NEW YORK, 10154
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2014 - BLACKSTONE SENFINA ADVISORS L.L.C.
Around the Web
- Blackstone Group’s $3B Americold bid nixed
By Josh Kosman - Wednesday Sep 27, 2017
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Cuomo will let companies name subway stops — for a price
By Carl Campanile - Thursday Jul 27, 2017
New York companies will get naming rights to subway station if they contribute at least $600,00 for upkeep Gov. Cuomo announced Thursday. “We want the private sector as full partners,” Cuomo said at an Association for a Better New York breakfast in Midtown. Blackstone and Estée Lauder are among the subway donors that Cuomo mentioned...
- For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
By Ben Fidler - Wednesday Aug 9, 2017
A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]